Key Highlights

  • Second-quarter revenue was $2,063.5 million, up 1.2%.
  • Adjusted diluted EPS fell to $2.56 from $3.52.
  • Gross bookings grew 24.1% and backlog reached $23.4 billion.
  • Net business wins were $3,120 million, a book-to-bill of 1.51.

ICON plc (NASDAQ:ICLR), the Dublin-based contract research organisation, reported second-quarter 2026 results that combined soft profitability with strong demand indicators. Adjusted diluted EPS fell to $2.56 from $3.52 a year earlier, yet gross bookings grew 24.1% and the backlog reached $23.4 billion. The focus is on how bookings convert into revenue and how margins may recover.

Latest Company Context

For the quarter ended June 30, 2026, ICON reported revenue of $2,063.5 million, up 1.2% (0.4% in constant currency). Adjusted EBITDA was $327.2 million, or 15.9% of revenue, down 21.7% year on year. GAAP net income was $72.6 million, or $0.94 per diluted share, compared with $2.56 in the second quarter of 2025, while adjusted net income was $198.4 million. Net business wins were $3,120 million, a book-to-bill ratio of 1.51, and cancellations were $562 million. Cash was $928.4 million, and net debt was $2.5 billion, or 1.8 times adjusted EBITDA. CEO Barry Balfe described "measured progress" and said "the underlying fundamentals of our business remain solid."

Key Business Drivers

Management reaffirmed 2026 guidance for revenue of $7,850 million to $8,150 million and adjusted diluted EPS of $10.00 to $11.00. Management also noted that second-half results remain subject to variability, particularly in pass-through activity, which can affect reported revenue without contributing much to profit. Free cash flow in the quarter was $238.9 million. The company reported no share repurchases in the first half of 2026, whereas the first half of 2025 included a $500.0 million buyback. With net debt at 1.8 times adjusted EBITDA, balance-sheet flexibility is a factor investors may weigh against the case for resuming repurchases.

What Investors Should Watch

The central question is conversion: a book-to-bill of 1.51 and a $23.4 billion backlog suggest a sizeable pipeline, but revenue growth of only 1.2% shows that timing and cancellations matter. Investors may watch the third-quarter report for signs that margins are stabilising, since the adjusted EBITDA decline was steep. The guidance range for adjusted EPS of $10.00 to $11.00 implies a meaningful second-half step-up relative to the first-half run rate, which could make delivery a focus. Cancellation trends, biotech funding conditions and any decision on capital returns may also shape sentiment.

Soft Profitability Beside Strong Bookings

ICON's quarter paired soft profitability with strong bookings, leaving margin recovery and bookings-to-revenue conversion as the key variables. Net debt of $2.5 billion, or 1.8 times adjusted EBITDA, adds a balance-sheet dimension.